argenx SE reported $10.03B in Assets for its fiscal quarter ending in June of 2026.





Assets Change Date
AstraZeneca USD 115.83B 1.82B Jun/2026
Genmab DKK 12.52B 139M Jun/2026
GlaxoSmithKline GBP 61.74B 1.13B Jun/2026
GRIFOLS EUR 20.09B 12M Jun/2026
Hikma Pharmaceutical USD 5.67B 117M Dec/2025
Lakefront Biotherapeutics EUR 3.35B 21.24M Jun/2026
Qiagen NV USD 5.89B 107.14M Jun/2026
UCB EUR 18.16B 971M Dec/2025